IL33 and colitis: iTcES also reduced the production of IL-33, a cytokine that is overexpressed in colitis (Palmieri et al. 2021; Pastorelli et al. 2010; Qiu et al. 2020; Schumacher et al. 2024), suggesting reduced damage to colonic tissue.